An odd press release from Major League Baseball just now:
“The Office of the Commissioner investigated all allegations regarding players associated with Anthony Bosch and Biogenesis. The investigation found no violation by Miguel Tejada of the Joint Drug Prevention and Treatment Program.”
This coming on the heels of reports earlier this week that Tejada was mentioned in the Biogenesis documents and faced discipline thereunder unless he accepted a suspension for stimulant use.
Either those reports were wrong or else Major League Baseball doesn’t want to look like it engaged in drug suspension horse-trading.
Ken Rosenthal of The Athletic reported on Monday night that the Blue Jays have signed outfielder Curtis Granderson to a one-year, $5 million deal. The contract is pending a physical and includes performance incentives.
Granderson, who turns 37 years old in March, spent last season with the Mets and Dodgers, batting an aggregate .212/.323/.452 with 26 home runs and 64 RBI in 527 plate appearances. He struggled offensively after going to the Dodgers, mustering a paltry .654 OPS. He went 1-for-15 in the playoffs as well.
The Blue Jays will likely platoon Granderson in the corner outfield. His career OPS is 158 points higher versus right-handed pitchers than against left-handers.